Aldeyra Therapeutics Inc’s recently made public that its Principal Financial Officer Alfieri Michael acquired Company’s shares for reported $13250.0 on
Aldeyra Therapeutics Inc’s recent filing unveils that its Principal Financial Officer Alfieri Michael acquired Company’s shares for reported $13250.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Aldeyra Therapeutics Inc revealed its Principal Financial Officer Alfieri Michael acquired Company’s shares for reported $13250.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Aldeyra Therapeutics Inc revealed its 10% Owner PERCEPTIVE ADVISORS LLC unloaded Company’s shares for reported $4.83 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Aldeyra Therapeutics Inc revealed its 10% Owner PERCEPTIVE ADVISORS LLC unloaded Company’s shares for reported $4.83 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or